Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia

Asikainen, 2007, HIF stabilizing agents: shotgun or scalpel?, Am. J. Physiol. Lung Cell. Mol. Physiol, 293, L555, 10.1152/ajplung.00251.2007 Stevens, 2007, Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome, Cochrane Database Syst. Rev., 4, CD003063 1995, NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes, JAMA, 273, 413, 10.1001/jama.1995.03520290065031 Roberts, 2006, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst. Rev., 3, CD004454 Avery, 1987, Is chronic lung disease in low birth weight infants preventable? A survey of eight centers, Pediatrics, 79, 26, 10.1542/peds.79.1.26 Fischer, 2013, Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis, Pediatrics, 132, e1351, 10.1542/peds.2013-1880 Coalson, 2003, Pathology of new bronchopulmonary dysplasia, Semin. Neonatol, 8, 73, 10.1016/S1084-2756(02)00193-8 Ali, 2013, Bronchopulmonary dysplasia: a review, Arch. Gynecol. Obstet., 288, 325, 10.1007/s00404-013-2753-8 Stroustrup, 2010, Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993–2006, Pediatrics, 126, 291, 10.1542/peds.2009-3456 Jobe, 1999, The new BPD: an arrest of lung development, Pediatr. Res., 46, 641, 10.1203/00006450-199912000-00007 Bancalari, 2003, Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition, Semin. Neonatol, 8, 63, 10.1016/S1084-2756(02)00192-6 Vento, 2009, Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease, Pediatrics, 124, e439, 10.1542/peds.2009-0434 Vento, 2001, Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates, Pediatrics, 107, 642, 10.1542/peds.107.4.642 Castro, 2009, Strategic plan for pediatric respiratory diseases research: an NHLBI working group report, Proc. Am. Thorac. Soc, 6, 1, 10.1513/pats.200810-116CB Rancourt, 2001, The role of p21(CIP1/WAF1) in growth of epithelial cells exposed to hyperoxia, Am. J. Physiol. Lung Cell. Mol. Physiol, 280, L617, 10.1152/ajplung.2001.280.4.L617 Helt, 2001, p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity, Toxicol. Sci., 63, 214, 10.1093/toxsci/63.2.214 Yee, 2009, Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity, Am. J. Physiol. Lung Cell. Mol. Physiol, 297, L641, 10.1152/ajplung.00023.2009 Jones, 2008, Radical-free biology of oxidative stress, Am. J. Physiol. Cell Physiol, 295, C849, 10.1152/ajpcell.00283.2008 Winterbourn, 2008, Thiol chemistry and specificity in redox signaling, Free Radic. Biol. Med., 45, 549, 10.1016/j.freeradbiomed.2008.05.004 Jones, 2006, Redefining oxidative stress, Antioxid. Redox Signaling, 8, 1865, 10.1089/ars.2006.8.1865 Go, 2013, The redox proteome, J. Biol. Chem., 288, 26512, 10.1074/jbc.R113.464131 Martin, 1995, fold for all reasons, Structure, 3, 245, 10.1016/S0969-2126(01)00154-X Deponte, 2013, Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes, Biochim. Biophys. Acta, 1830, 3217, 10.1016/j.bbagen.2012.09.018 Mieyal, 2008, Molecular mechanisms and clinical implications of reversible protein S-glutathionylation, Antioxid. Redox Signaling, 10, 1941, 10.1089/ars.2008.2089 Lillig, 2008, Glutaredoxin systems, Biochim. Biophys. Acta, 1780, 1304, 10.1016/j.bbagen.2008.06.003 Eckers, 2009, Biochemical characterization of dithiol glutaredoxin 8 from Saccharomyces cerevisiae: the catalytic redox mechanism redux, Biochemistry, 48, 1410, 10.1021/bi801859b Rhee, 2005, Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling, Free Radic. Biol. Med., 38, 1543, 10.1016/j.freeradbiomed.2005.02.026 Toppo, 2009, Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme, Biochim. Biophys. Acta, 1790, 1486, 10.1016/j.bbagen.2009.04.007 Brigelius-Flohe, 2013, Glutathione peroxidases, Biochim. Biophys. Acta, 1830, 3289, 10.1016/j.bbagen.2012.11.020 Karplus, 1989, Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2A resolution, J. Mol. Biol., 210, 163, 10.1016/0022-2836(89)90298-2 Holmgren, 1985, Annu. Rev. Biochem., 54, 237, 10.1146/annurev.bi.54.070185.001321 Fukuse, 1995, Attenuation of ischaemia reperfusion injury by human thioredoxin, Thorax, 50, 387, 10.1136/thx.50.4.387 Didier, 2001, Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts, Free Radic. Biol. Med., 31, 585, 10.1016/S0891-5849(01)00617-7 Sachi, 1995, Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells, Immunol. Lett., 44, 189, 10.1016/0165-2478(95)00213-O Spector, 1988, The effect of H2O2 upon thioredoxin-enriched lens epithelial cells, J. Biol. Chem., 263, 4984, 10.1016/S0021-9258(18)68884-2 Haendeler, 2004, Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression, FEBS Lett., 577, 427, 10.1016/j.febslet.2004.10.041 Schroeder, 2007, Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells—important role for nuclear thioredoxin-1, Arterioscler. Thromb. Vasc. Biol., 27, 2325, 10.1161/ATVBAHA.107.149419 Das, 2004, Thioredoxin system in premature and newborn biology, Antioxid. Redox Signaling, 6, 177, 10.1089/152308604771978480 Das, 1999, Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen, Am. J. Physiol., 276, L530 Nakamura, 2005, Redox regulation of lung inflammation by thioredoxin, Antioxid. Redox Signaling, 7, 60, 10.1089/ars.2005.7.60 Tipple, 2007, Thioredoxin-related mechanisms in hyperoxic lung injury in mice, Am. J. Respir. Cell Mol. Biol., 37, 405, 10.1165/rcmb.2006-0376OC Tipple, 2009, Alterations of the thioredoxin system by hyperoxia: implications for alveolar development, Am. J. Respir. Cell Mol. Biol., 41, 612, 10.1165/rcmb.2008-0224OC Yee, 2006, Type II epithelial cells are a critical target for hyperoxia-mediated impairment of postnatal lung development, Am. J. Physiol. Lung Cell. Mol. Physiol, 291, L1101, 10.1152/ajplung.00126.2006 Farrell, 2010, Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity, Free Radic. Biol. Med., 49, 1361, 10.1016/j.freeradbiomed.2010.07.016 Reddy, 2007, Deficiency in Nrf2–GSH signaling impairs type II cell growth and enhances sensitivity to oxidants, Am. J. Respir. Cell Mol. Biol., 37, 3, 10.1165/rcmb.2007-0004RC Chen, 2010, Thioredoxin protects fetal type II epithelial cells from hyperoxia-induced injury, Pediatr. Pulmonol., 45, 1192, 10.1002/ppul.21307 Yamada, 2007, Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls, Pulm. Pharmacol. Ther., 20, 650, 10.1016/j.pupt.2006.07.004 Holmgren, 1982, The in vivo distribution of oxidized and reduced thioredoxin in Escherichia coli, J. Biol. Chem., 257, 6926, 10.1016/S0021-9258(18)34518-6 Fernando, 1992, Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells, Eur. J. Biochem., 209, 917, 10.1111/j.1432-1033.1992.tb17363.x Watson, 2003, Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif, J. Biol. Chem., 278, 33408, 10.1074/jbc.M211107200 Liu, 2000, Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin, Mol. Cell. Biol., 20, 2198, 10.1128/MCB.20.6.2198-2208.2000 Vitiello, 2006, p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth, Am. J. Pathol., 168, 1838, 10.2353/ajpath.2006.051162 Brill, 2009, Comprehensive proteomic analysis of Schizosaccharomyces pombe by two-dimensional HPLC-tandem mass spectrometry, Methods, 48, 311, 10.1016/j.ymeth.2009.02.023 Das, 1999, Hyperoxia induces thioredoxin and thioredoxin reductase gene expression in lungs of premature baboons with respiratory distress and bronchopulmonary dysplasia, Chest, 116, 101S, 10.1016/S0012-3692(15)30700-5 Verdoucq, 1999, In vivo characterization of a thioredoxin h target protein defines a new peroxiredoxin family, J. Biol. Chem., 274, 19714, 10.1074/jbc.274.28.19714 Morinaka, A., et al. Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone collapse. Sci. Signaling 4, ra26 (2011). Nordberg, 2001, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system, Free Radic. Biol. Med., 31, 1287, 10.1016/S0891-5849(01)00724-9 Shan, 2011, Effects of hyperoxia on cytoplasmic thioredoxin system in alveolar type epithelial cells of premature rats, J. Huazhong Univ. Sci. Technol. Med. Sci, 31, 258, 10.1126/scisignal.2001127 Maher, 2000, Signaling by reactive oxygen species in the nervous system, Cell. Mol. Life Sci., 57, 1287, 10.1007/PL00000766 Finkel, 2000, Oxidants, oxidative stress and the biology of ageing, Nature, 408, 239, 10.1038/35041687 Thomas, 2001, Aging and oxidation of reactive protein sulfhydryls, Exp. Gerontol., 36, 1519, 10.1016/S0531-5565(01)00137-1 Jones, 2010, sensing: orthogonal control in cell cycle and apoptosis signalling, J. Intern. Med., 268, 432, 10.1111/j.1365-2796.2010.02268.x Tan, 2010, The thioredoxin–thioredoxin reductase system can function in vivo as an alternative system to reduce oxidized glutathione in Saccharomyces cerevisiae, J. Biol. Chem., 285, 6118, 10.1074/jbc.M109.062844 Du, 2012, Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose, J. Biol. Chem., 287, 38210, 10.1074/jbc.M112.392225 Halvey, 2005, Compartmental oxidation of thiol–disulphide redox couples during epidermal growth factor signalling, Biochem. J., 386, 215, 10.1042/BJ20041829 Watson, 2003, Oxidation of nuclear thioredoxin during oxidative stress, FEBS Lett., 543, 144, 10.1016/S0014-5793(03)00430-7 Go, 2010, Redox control systems in the nucleus: mechanisms and functions, Antioxid. Redox Signaling, 13, 489, 10.1089/ars.2009.3021 Go, 2008, Redox compartmentalization in eukaryotic cells, Biochim. Biophys. Acta, 1780, 1273, 10.1016/j.bbagen.2008.01.011 Yoshioka, 2006, Role of thioredoxin in cell growth through interactions with signaling molecules, Antioxid. Redox Signaling, 8, 2143, 10.1089/ars.2006.8.2143 Gallegos, 1996, Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells, Cancer Res., 56, 5765 Powis, 1997, Selenium and the thioredoxin redox system: effects on cell growth and death, Oncol. Res., 9, 303 Nakamura, 1997, Redox regulation of cellular activation, Annu. Rev. Immunol., 15, 351, 10.1146/annurev.immunol.15.1.351 Hayashi, 1993, Oxidoreductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin, J. Biol. Chem., 268, 11380, 10.1016/S0021-9258(18)82135-4 Saitoh, 1998, Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, EMBO J., 17, 2596, 10.1093/emboj/17.9.2596 Ueno, 1999, Thioredoxin-dependent redox regulation of p53-mediated p21 activation, J. Biol. Chem., 274, 35809, 10.1074/jbc.274.50.35809 Welsh, 2003, The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation, Mol. Cancer Ther, 2, 235 Hirota, 2000, Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells, Biochem. Biophys. Res. Commun., 274, 177, 10.1006/bbrc.2000.3106 Wei, 2000, Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation, Cancer Res., 60, 6688 Kambe, 1996, Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells, Mol. Endocrinol., 10, 801 DeFelice, 2003, TTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival, and tissue-specific gene expression, J. Biol. Chem., 278, 35574, 10.1074/jbc.M304885200 Wert, 2002, Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation, Dev. Biol., 242, 75, 10.1006/dbio.2001.0540 Tell, 2002, Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain, J. Biol. Chem., 277, 14564, 10.1074/jbc.M200582200 Wynn, 1995, Mixed disulfide intermediates during the reduction of disulfides by Escherichia coli thioredoxin, Biochemistry, 34, 11807, 10.1021/bi00037a019 Nikkanen, 2014, Thioredoxin-dependent regulatory networks in chloroplasts under fluctuating light conditions, Philos. Trans. R. Soc. London B Biol. Sci, 369, 20130224, 10.1098/rstb.2013.0224 Serrato, 2013, Plastid thioredoxins: a one-for-all redox-signaling system in plants, Front. Plant Sci., 4, 463, 10.3389/fpls.2013.00463 Kawazu, 2010, Target proteins of the cytosolic thioredoxin in Plasmodium falciparum, Parasitol. Int., 59, 298, 10.1016/j.parint.2010.03.005 Pearl, 2006, Structure and mechanism of the Hsp90 molecular chaperone machinery, Annu. Rev. Biochem., 75, 271, 10.1146/annurev.biochem.75.103004.142738 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Beck, 2011, Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies, Curr. Med. Chem., 18, 2816, 10.2174/092986711796011256 Sreedhar, 2003, Hsp90 inhibition accelerates cell lysis: anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events, J. Biol. Chem., 278, 35231, 10.1074/jbc.M301371200 Dikalov, 2002, Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling: implications for studies of Hsp90 and endothelial cell nitric-oxide synthase, J. Biol. Chem., 277, 25480, 10.1074/jbc.M203271200 Clark, 2009, Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex, Free Radic. Biol. Med., 47, 1440, 10.1016/j.freeradbiomed.2009.08.012 Nardai, 2000, Reactive cysteines of the 90-kDa heat shock protein, Hsp90, Arch. Biochem. Biophys., 384, 59, 10.1006/abbi.2000.2075 Sarkar, 2013, Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo, Int. J. Cancer, 132, 695, 10.1002/ijc.27687 Chen, 2008, Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins, J. Biol. Chem., 283, 17184, 10.1074/jbc.M709447200 Cumming, 2004, Protein disulfide bond formation in the cytoplasm during oxidative stress, J. Biol. Chem., 279, 21749, 10.1074/jbc.M312267200 Benhar, 2008, Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins, Science, 320, 1050, 10.1126/science.1158265 Stoyanovsky, 2005, Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols, J. Am. Chem. Soc., 127, 15815, 10.1021/ja0529135 Benhar, 2009, Protein denitrosylation: enzymatic mechanisms and cellular functions, Nat. Rev. Mol. Cell Biol., 10, 721, 10.1038/nrm2764 Wu, 2011, Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach, J. Proteomics, 74, 2498, 10.1016/j.jprot.2011.06.001 Wu, 2010, Redox regulatory mechanism of transnitrosylation by thioredoxin, Mol. Cell. Proteomics, 9, 2262, 10.1074/mcp.M110.000034 Martinez-Ruiz, 2005, S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities, Proc. Natl. Acad. Sci. USA, 102, 8525, 10.1073/pnas.0407294102 Thebaud, 2007, Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease, Am. J. Respir. Crit. Care Med., 175, 978, 10.1164/rccm.200611-1660PP Galambos, 2002, Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms, Am. J. Respir. Cell Mol. Biol., 27, 194, 10.1165/ajrcmb.27.2.4703 Maniscalco, 1997, Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung, Am. J. Respir. Cell Mol. Biol., 16, 557, 10.1165/ajrcmb.16.5.9160838 Kunig, 2005, Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats, Am. J. Physiol. Lung Cell. Mol. Physiol, 289, L529, 10.1152/ajplung.00336.2004 Isaacs, 2002, Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway, J. Biol. Chem., 277, 29936, 10.1074/jbc.M204733200 Aschner, 2007, Heat shock protein 90 modulates endothelial nitric oxide synthase activity and vascular reactivity in the newborn piglet pulmonary circulation, Am. J. Physiol. Lung Cell. Mol. Physiol, 292, L1515, 10.1152/ajplung.00252.2006 Aschner, 2009, Heat shock protein 90–eNOS interactions mature with postnatal age in the pulmonary circulation of the piglet, Am. J. Physiol. Lung Cell. Mol. Physiol, 296, L555, 10.1152/ajplung.90456.2008 Sud, 2007, Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90, Am. J. Physiol. Lung Cell. Mol. Physiol, 293, L1444, 10.1152/ajplung.00175.2007 Basso, 2002, Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function, J. Biol. Chem., 277, 39858, 10.1074/jbc.M206322200 Fortugno, 2003, Regulation of survivin function by Hsp90, Proc. Natl. Acad. Sci. USA, 100, 13791, 10.1073/pnas.2434345100 Gasdaska, 1995, Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism, Cell Growth Differ., 6, 1643 Kaner, 2001, Crystal, R.G. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung, Mol. Med., 7, 240, 10.1007/BF03401843 Schulze, 2002, Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin, Circ. Res., 91, 689, 10.1161/01.RES.0000037982.55074.F6 Aykin-Burns, 2009, Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation, Biochem. J., 418, 29, 10.1042/BJ20081258 Corti, 2010, Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting, Anticancer Res., 30, 1169 Scarbrough, 2012, Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress, Free Radic. Biol. Med., 52, 436, 10.1016/j.freeradbiomed.2011.10.493